Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
Neurobiology of Learning and Memory May 25, 2021 Igor Magaraggia, Zilla Kuiperes, Rudy Schreiber 49 citations
The high symptomatic and biological heterogeneity of major depressive disorder (MDD) makes it very difficult to find broadly efficacious treatments that work against all symptoms. Concentrating on single core symptoms that are biologically well understood might consist of a more viable approach. The Research Domain Criteria (RDoC) framework is a trans-diagnostic dimensional approach that...